Cargando…
Utility of Islet Cell Preparations From Donor Pancreases After Euthanasia
Patients fulfilling criteria for euthanasia can choose to donate their organs after circulatory death [donors after euthanasia (DCD V)]. This study assesses the outcome of islet cell isolation from DCD V pancreases. A procedure for DCD V procurement provided 13 pancreases preserved in Institut Georg...
Autores principales: | De Paep, Diedert L., Van Hulle, Freya, Ling, Zhidong, Vanhoeij, Marian, Hilbrands, Robert, Distelmans, Wim, Gillard, Pieter, Keymeulen, Bart, Pipeleers, Daniel, Jacobs-Tulleneers-Thevissen, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125111/ https://www.ncbi.nlm.nih.gov/pubmed/35583214 http://dx.doi.org/10.1177/09636897221096160 |
Ejemplares similares
-
Lower beta cell yield from donor pancreases after controlled circulatory death prevented by shortening acirculatory warm ischemia time and by using IGL-1 cold preservation solution
por: De Paep, Diedert L., et al.
Publicado: (2021) -
Differences in Baseline Lymphocyte Counts and Autoreactivity Are Associated With Differences in Outcome of Islet Cell Transplantation in Type 1 Diabetic Patients
por: Hilbrands, Robert, et al.
Publicado: (2009) -
Pancreatic Duct Cells in Human Islet Cell Preparations Are a Source of Angiogenic Cytokines Interleukin-8 and Vascular Endothelial Growth Factor
por: Movahedi, Babak, et al.
Publicado: (2008) -
Insulitis in the pancreas of non-diabetic organ donors under age 25 years with multiple circulating autoantibodies against islet cell antigens
por: Smeets, Silke, et al.
Publicado: (2021) -
Graves Hyperthyroidism After Stopping Immunosuppressive Therapy in Type 1 Diabetic Islet Cell Recipients With Pretransplant TPO Autoantibodies
por: Gillard, Pieter, et al.
Publicado: (2009)